Thus, our study identifies a potential UBE2Q1 – B4GALT3 functional axis in breast and ovarian cancer, where only the E2 conjugating enzyme showed a poor prognostic impact on the disease. The gene discussed is B4GALT3; the disease is ovarian carcinoma.